Modern Aspects of the Use of Antiagregatant and Hypolipodemic Therapy After Coronary Artery Stent Surgery
Keywords:
Coronary artery disease, Antiplatelet therapy, Hypolipidemic therapy, StentingAbstract
This article will discuss current issues and modern problems of coronary heart disease, antiplatelet therapy, its effects, hypolipidemic therapy, indications, contraindications, possible side effects, as well as successful tactics of patient management after percutaneous coronary intervention with subsequent use of drug eluting stents.
References
Alyavi A. and Uzokov J. Treatment of stable angina pectoris: attention to the role of calcium antagonists and ACE inhibitors. Ont Health Technol Assess Series. 2017; 15(9): 1-12.
Alyavi B, Uzokov J, Abdullaev A, Paiziev D, Mukhitdinova O. Effect of low glycemic index diet on proinflammatory interleukins in patients with metabolic syndrome and coronary heart disease. MetabolismClinical and experimental. 2021; 116.
Alyavi A, Alyavi B, Uzokov J. Prognostic value of metabolic syndrome for the development of type 2 diabetes mellitus and cardiovascular disease. Atherosclerosis. 2020; 315: e180.
Payziev D, Azizov SI, Uzokov JK, Iskhakov SA. P1003 New onset of atrial fibrillation after right coronary artery stenting in patients with coronary heart disease. EP Europace. 2020; 22(S1): 162-338.
Uzokov Y, Alyavi B. Efficacy of clopidogrel in patients with coronary heart disease after PCI taking into account genetic polymorphisms. Atherosclerosis. 2020; 315: e84.
Mamatkulov H.A., Usarov M.H., Uzokov J.K., Arzieva J.B. Effect of interventional myocardial revascularization in patients with acute myocardial infarction without “q” wave. O 'zbekiston terapiya axborotnomasi. 2015; 2: 18.
Uzokov J, Alyavi B, Paiziev D. Effect of low glycemic index diet on triglyceride levels, glycated hemoglobin and LDL/HDL ratio in patients with coronary heart disease. Atherosclerosis. 2020; 315: e253. SRC Biological and Pharmaceutical Sciences, 2021, 15(03), 212-217 216
Bath PM, Woodhouse LJ, Appleton JP, Beridze M, Christensen H, Dineen RA, Broughton D. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomized, open-label, phase 3 superiority trial. The Lancet. 2018; 391(10123): 850-859.
Araiza-Garaygordobil D, Montalto C, Martinez-Amezcua P, Cabello-Lopez A, Gopar-Nieto R, Alabrese R, Tavazzi G. Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study. QJM: An International Journal of Medicine. 2021; 1-6.
Uzokov J, Alyavi B, Abdullaev A. Effect of combined lipid-lowering therapy on lipid components and interleukins in patients with dyslipidemia and coronary heart disease after PCI. Atherosclerosis. 2020; 315: e280.
Matić I, Froelicher ES, Uzokov J, Ljubas A. A Survey on Cardiovascular Nursing Occupational Standard: Meeting the needs of employers. Policy, Politics, & Nursing Practice. 2020.
Uzokov JK, Alyavi BA, Abdullaev AX. Evaluation of clopidogrel action taking into account CYP2C19 gene polymorphisms in patients with coronary heart disease after stent implantation. Euroasian Card J, S2. 2019; 309-309.
Alyavi B, Uzokov JK, Abdullaev AX, Payziev DD. P427 Effect of ranolazine on the frequency of cardioversions in patients with recent onset atrial fibrillation and ischemic heart disease. EP Europace. 2020; 22(S1): 162-337.
Alyavi AL, Alyavi BA, Uzokov J, Abdullaev AX. P1001 Efficacy of ranolazine for prevention of atrial fibrillation in high-risk patients with chronic coronary syndrome and arterial hypertension. EP Europace. 2020; 22(Supplement_1): euaa162-354.
Payziev D, Azizov SI, Uzokov JK, Iskhakov SA. P1003 New onset of atrial fibrillation after right coronary artery stenting in patients with coronary heart disease. EP Europace. 2020; 22(Supplement_1): euaa162- 338.
Resor CD, Nathan A, Kereiakes DJ, Yeh RW, Massaro JM, Cutlip DE, Mauri L. Impact of optimal medical therapy in the dual antiplatelet therapy study. Circulation. 2016; 134(14): 989-998.
Uzokov J, Alyavi A, Alyavi B, Azizov S. Influence of Combined Therapy on Inflammatory State and Proinflammatory Cytokines in Patients with Coronary Artery Disease and Metabolic Syndrome. European Heart Review. 2020; 15.
Gafurdjanovna MM, Saidjanovna ND, Jamol U. Efficacy of rosuvastatin on lipid parameters and vascular inflammatory markers in patients with metabolic syndrome and coronary heart disease. Journal of Critical Reviews. 2020; 7(19): 8112-8115.
Alyavi A, Alyavi B, Tulyaganova D, Sabirjanova Z, Nuritdinova S, Kayumova N, Uzokov J. Distribution of tumor necrosis factor-α and interleukin-6 genes in patients with ischemic heart disease. Journal of Critical Reviews. 2020; 7(19): 7441-7449.
Uzokov J. Coronary artery health and changes in lipid profile in coronary heart disease. Age. 2020; 62(7): 3-09.
Bekbaulieva GN, Abduraimova GA, Razzakova NS, Uzokov J. Impact of technologies of effective perinatal care on the work of obstetric complexes. Journal of Critical Reviews. 2020; 7(9): 1182-1184.
Uzokov J, Alyavi AL, Alyavi BA, Iskhakov SA, Payziev DD. P3570 Bilateral renal artery stenting is an effective method for the treatment of uncontrolled hypertension and renal dysfunction. European Heart Journal. 2019; 40(Supplement_1): ehz745-0432.
Abdullaev A.H., Alyavi B.A., Iskhakov S.Sh., Uzakov J.K., Ibabekova S.R., Yunusova L.I., Azizov S.Sh. Some indices of biochemical studies and echocardiography in patients with ischemic heart disease who underwent stenting. In VI Eurasian Congress of Cardiologists. 2018; 76.
Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A, Cosyns B. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Heart J-Qual C Clin Out. 2019; 5(3): 202-207. [25] Alyavi BA, et al. Clinical case of endovascular treatment of chronic cerebral arterial insufficiency in a patient with critical ischemia of the lower extremities. Bukovynskiy medical visnik. 2018; 22(2): 86.
Uzokov JK, Alyavi AL, Alyavi BA, Kayumov NU. P269 Prognostic role of coronary artery calcium score in patients with metabolic syndrome. European Heart Journal-Cardiovascular Imaging. 2019; 20(Supplement_3): jez148- 001. GSC Biological and Pharmaceutical Sciences, 2021, 15(03), 212–217 217
Alyavi A, et al. Influence of Diet with Low Glycemic Index on Lipid Spectrum in Patients with Ischemic Disease of the Heart. Atherosclerosis Supplements. 2018; (32): 158.
Radjabova DI, Alyavi AL, Alyavi BA, Tulyaganova DK, Uzokov JK, Shodiev JD, Nuritdinova SK. The Features of Cytokine Status in Patients with Coronary Heart. 2018.
Alyavi BA, et al. On an integrated approach to the treatment and rehabilitation of patients with ischemic heart disease. Eurasian Journal of Cardiology. 2019; S2: 154-154.
Uzokov JK, Alyavi BA, Abdullaev AX. Combined therapy with rosuvastatin and ezetimibe on inflammatory state and pro-inflammatory cytokines in patients with coronary heart disease and metabolic syndrome. European journal of heart failure. 2019; 111: 07030-5774.
Alyavi BA, et al. The functional state of the liver in patients with ischemic heart disease. Eurasian Journal of Cardiology. 2019; S2: 155-155.
Uzokov J. Influence of abnormal lipid components in statin-naive young adults: Is there any gap?. Eur J Prev Card. 2020; 27(8): 868–869.
Lyutfullayevich AA, et al. Relationship between hemodynamic parametres and NPPA, NPPB, NPR3 genes polymorphism in patients with ischemic heart disease. International scientific review. 2017; 7(38).
Alyavi AL, et al. Predictors of contrast induced nephropathy in patients with metabolic syndrome. Eur Heart J. 2017; 38: 1283-1283.
Babaev M, et al. Influence of l-arginine aspartate on vascular markers in hypertensive patients with metabolic syndrome. Eur Heart J. 2018; 39: 495-495.
Alyavi BA, et al. Influence of lipid-lowering and antiplatelet therapy on some biochemical and ultrasound parameters of patients with ischemic heart disease who underwent stenting. Cardiovascular Therapy and Prevention. 2019; 18 (S1): 12-13.
Alyavi B, Alyavi A, Uzokov J. Role of pro-inflammatory cytokines in metabolic syndrome. In ALLERGY. 2018 August; 73: 562-562.
Iskhakov S, et al. Comparative Analysis of The Inflammatory Biomarkers In Patients With Stable Coronary Artery Disease And Metabolic Syndrome. Atherosclerosis. 2019; 287: e171.
Lutfullayevich AA, et al. GW28-e0698 Telmisartan with amlodipine versus lisinopril with amlodipine on home blood pressure variability in patients with metabolic syndrome. J Amer Coll Card. 2017; 70(16): 138.
Usarov M, et al. Efficacy of Combination Therapy Using Nebivalol and Trimetazidine In Hypertensive Patients With Metabolic Syndrome And Stable Angina. J Hyperten. 2016; 34: e349.
Lutfullayevich AA, et al. Cardiovascular risk stratification and gender differences in hypertensive patients with metabolic syndrome. J Amer Col Card. 2017; 70(16): 138-139.
Mukhamedova M, et al. P120 Relationship between left ventricular global function index and cardiac systolic functions in patients with chronic ischemic disease of the heart and diabetes mellitus. Eur Heart J-Card Imag. 2019; 20(S3): 147, 008.
Ahmedov I, et al. Features of hyperreninemic aldosteronism in hypertension patients with metabolic syndrome. Eur J Prev Card. 2016; 23(1).
Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Oliver L. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019; 40(39): 3222-3232
